281 related articles for article (PubMed ID: 24736076)
21. Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study.
Cui Y; Chen W; Kong FM; Olsen LA; Beatty RE; Maxim PG; Ritter T; Sohn JW; Higgins J; Galvin JM; Xiao Y
Pract Radiat Oncol; 2015; 5(2):e67-75. PubMed ID: 25413413
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Ray Tracing and Monte Carlo Calculation Algorithms for Thoracic Spine Lesions Treated With CyberKnife-Based Stereotactic Body Radiation Therapy.
Okoye CC; Patel RB; Hasan S; Podder T; Khouri A; Fabien J; Zhang Y; Dobbins D; Sohn JW; Yuan J; Yao M; Machtay M; Sloan AE; Miller J; Lo SS
Technol Cancer Res Treat; 2016 Feb; 15(1):196-202. PubMed ID: 25633137
[TBL] [Abstract][Full Text] [Related]
23. Treatment of non-small cell lung cancer patients with proton beam-based stereotactic body radiotherapy: dosimetric comparison with photon plans highlights importance of range uncertainty.
Seco J; Panahandeh HR; Westover K; Adams J; Willers H
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):354-61. PubMed ID: 21985941
[TBL] [Abstract][Full Text] [Related]
24. Setting up a lung stereotactic body radiotherapy service in a tertiary center in Eastern India: The process, quality assurance, and early experience.
Shrimali RK; Saha A; Arun B; Prasath S; Nallathambi C; Bhoumik S; Mallick I; Achari RB; Chatterjee S
J Cancer Res Ther; 2020; 16(4):888-899. PubMed ID: 32930136
[TBL] [Abstract][Full Text] [Related]
25. Enhancing safety and quality through preplanning peer review for patients undergoing stereotactic body radiation therapy.
Matuszak MM; Hadley SW; Feng M; Hayman JA; Brock KK; Burger P; Owen D; Suresh K; Schipper M; Lawrence TS; Moran JM
Pract Radiat Oncol; 2016; 6(2):e39-46. PubMed ID: 26746815
[TBL] [Abstract][Full Text] [Related]
26. Incorporating heterogeneity correction and 4DCT in lung stereotactic body radiation therapy (SBRT): The effect on target coverage, organ-at-risk doses, and dose conformity.
Franks KN; Purdie TG; Dawson LA; Bezjak A; Jaffray DA; Bissonnette JP
Med Dosim; 2010; 35(2):101-7. PubMed ID: 19931021
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic radiotherapy of intrapulmonary lesions: comparison of different dose calculation algorithms for Oncentra MasterPlan®.
Troeller A; Garny S; Pachmann S; Kantz S; Gerum S; Manapov F; Ganswindt U; Belka C; Söhn M
Radiat Oncol; 2015 Feb; 10():51. PubMed ID: 25888786
[TBL] [Abstract][Full Text] [Related]
28. Cleaning the dose falloff in lung SBRT plan.
Desai D; Narayanasamy G; Bimali M; Cordrey I; Elasmar H; Srinivasan S; Johnson EL
J Appl Clin Med Phys; 2021 Jan; 22(1):100-108. PubMed ID: 33285036
[TBL] [Abstract][Full Text] [Related]
29. Toxicity after central versus peripheral lung stereotactic body radiation therapy: a propensity score matched-pair analysis.
Mangona VS; Aneese AM; Marina O; Hymas RV; Ionascu D; Robertson JM; Gallardo LJ; Grills IS
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):124-32. PubMed ID: 25442337
[TBL] [Abstract][Full Text] [Related]
30. A treatment planning comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based stereotactic body radiotherapy for central early-stage non-small cell lung cancer.
Merna C; Rwigema JC; Cao M; Wang PC; Kishan AU; Michailian A; Lamb J; Sheng K; Agazaryan N; Low DA; Kupelian P; Steinberg ML; Lee P
Med Dosim; 2016; 41(1):87-91. PubMed ID: 26755076
[TBL] [Abstract][Full Text] [Related]
31. Stereotactic body radiotherapy: volumetric modulated arc therapy versus 3D non-coplanar conformal radiotherapy for the treatment of early stage lung cancer.
Herbert C; Kwa W; Nakano S; James K; Moiseenko V; Wu J; Schellenberg D; Liu M
Technol Cancer Res Treat; 2013 Dec; 12(6):511-6. PubMed ID: 23617285
[TBL] [Abstract][Full Text] [Related]
32. Dosimetric errors during treatment of centrally located lung tumors with stereotactic body radiation therapy: Monte Carlo evaluation of tissue inhomogeneity corrections.
Altunbas C; Kavanagh B; Dzingle W; Stuhr K; Gaspar L; Miften M
Med Dosim; 2013; 38(4):436-41. PubMed ID: 24119416
[TBL] [Abstract][Full Text] [Related]
33. Adaptive stereotactic body radiation therapy planning for lung cancer.
Qin Y; Zhang F; Yoo DS; Kelsey CR; Yin FF; Cai J
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):209-15. PubMed ID: 23790773
[TBL] [Abstract][Full Text] [Related]
34. Optimization of stereotactic body radiotherapy treatment planning using a multicriteria optimization algorithm.
Ghandour S; Cosinschi A; Mazouni Z; Pachoud M; Matzinger O
Z Med Phys; 2016 Dec; 26(4):362-370. PubMed ID: 27156924
[TBL] [Abstract][Full Text] [Related]
35. Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumours.
Hoffmann L; Persson GF; Nygård L; Nielsen TB; Borrisova S; Gaard-Petersen F; Josipovic M; Khalil AA; Kjeldsen R; Knap MM; Kristiansen C; Møller DS; Ottosson W; Sand H; Thing R; Pøhl M; Schytte T
Radiother Oncol; 2022 Jun; 171():53-61. PubMed ID: 35421513
[TBL] [Abstract][Full Text] [Related]
36. New dosimetric guidelines for linear Boltzmann transport equations through comparative evaluation of stereotactic body radiation therapy for lung treatment planning.
Webster M; Tanny S; Joyce N; Herman A; Chen Y; Milano M; Usuki K; Constine L; Singh D; Yeo I
J Appl Clin Med Phys; 2021 Dec; 22(12):115-124. PubMed ID: 34783438
[TBL] [Abstract][Full Text] [Related]
37. Dosimetric effects of rotational offsets in stereotactic body radiation therapy (SBRT) for lung cancer.
Yang Y; Catalano S; Kelsey CR; Yoo DS; Yin FF; Cai J
Med Dosim; 2014; 39(1):117-21. PubMed ID: 24485056
[TBL] [Abstract][Full Text] [Related]
38. Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy.
Modh A; Rimner A; Williams E; Foster A; Shah M; Shi W; Zhang Z; Gelblum DY; Rosenzweig KE; Yorke ED; Jackson A; Wu AJ
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1168-76. PubMed ID: 25303891
[TBL] [Abstract][Full Text] [Related]
39. A multi-institutional study to assess adherence to lung stereotactic body radiotherapy planning goals.
Woerner A; Roeske JC; Harkenrider MM; Fan J; Aydogan B; Koshy M; Laureckas R; Vali F; Campana M; Surucu M
Med Phys; 2015 Aug; 42(8):4629-35. PubMed ID: 26233190
[TBL] [Abstract][Full Text] [Related]
40. Calculating the individualized fraction regime in stereotactic body radiotherapy for non-small cell lung cancer based on uncomplicated tumor control probability function.
Lu JY; Lin PX; Huang BT
Radiat Oncol; 2019 Jun; 14(1):111. PubMed ID: 31221159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
